Contract facts
UnrestrictedGEN1E - THIS CONTRACT WILL PROVIDE SUPPORT TO GEN1E LIFESCIENCES INC. (GEN1E), A US COMPANY, FOR THE ADVANCEMENT OF PATIENT STRATIFICATION AND ENDOTYPING APPROACHES AS IT DEVELOPS GEN-1124, A NOVEL TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROME (A is a federal Unrestricted award for Barda - Aspr / Daappo / Barda Dcma held by Gen1e Lifesciences Inc. Estimated value $749K ($749K obligated). Current period of performance ends Dec 30, 2027. Last award drew 100 bidders. Place of performance: PALO ALTO CA.
GEN1E - THIS CONTRACT WILL PROVIDE SUPPORT TO GEN1E LIFESCIENCES INC. (GEN1E), A US COMPANY, FOR THE ADVANCEMENT OF PATIENT STRATIFICATION AND ENDOTYPING APPROACHES AS IT DEVELOPS GEN-1124, A NOVEL TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROME (A
Recompete timing
PublicCurrent PoP ends Dec 30, 2027 (459 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Want the durability read on 75A50123C00063? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordGen1e Lifesciences Inc — $749K obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50123C00063?
75A50123C00063 (Gen1e gen1e support) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $749K, currently held by Gen1e Lifesciences Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50123C00063?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50123C00063 to Gen1e Lifesciences Inc (potential $749K).
Who is the incumbent on 75A50123C00063?
Gen1e Lifesciences Inc is the incumbent with $749K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Dec 30, 2027.
When does Gen1e Lifesciences Inc’s 75A50123C00063 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75A50123C00063? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.